Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment

Li Zhang,1,* Mengchu Yao,2,3,* Wei Yan,4,* Xiaoning Liu,5 Baofei Jiang,6 Zhaoye Qian,2,3 Yong Gao,2,3 Xiao-jie Lu,7 Xiaofei Chen,2 Qi-long Wang2,3,5 1Department of Hematology, 2Department of Clinical Oncology, 3Huai’an Key Laboratory of Esophageal Cancer Biobank, 4Department of Gastroente...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang L, Yao M, Yan W, Liu X, Jiang B, Qian Z, Gao Y, Lu XJ, Chen X, Wang Q
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/d4e94891176e477cab489b28ec71d8bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d4e94891176e477cab489b28ec71d8bb
record_format dspace
spelling oai:doaj.org-article:d4e94891176e477cab489b28ec71d8bb2021-12-02T03:05:06ZDelivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment1178-2013https://doaj.org/article/d4e94891176e477cab489b28ec71d8bb2017-09-01T00:00:00Zhttps://www.dovepress.com/delivery-of-a-chemotherapeutic-drug-using-novel-hollow-carbon-spheres--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Li Zhang,1,* Mengchu Yao,2,3,* Wei Yan,4,* Xiaoning Liu,5 Baofei Jiang,6 Zhaoye Qian,2,3 Yong Gao,2,3 Xiao-jie Lu,7 Xiaofei Chen,2 Qi-long Wang2,3,5 1Department of Hematology, 2Department of Clinical Oncology, 3Huai’an Key Laboratory of Esophageal Cancer Biobank, 4Department of Gastroenterology, 5Department of Central Laboratory, 6Department of Gastrointestinal Surgery, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, 7Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China *These authors contributed equally to this work Abstract: Low toxicity and high efficacy are the key factors influencing the real-world clinical applications of nanomaterial-assisted drug delivery. In this study, novel hollow carbon spheres (HCSs) with narrow size distribution were developed. In addition to demonstrating their ease of synthesis for large-scale production, we also demonstrated in vitro that the HCSs possessed high drug-loading capacity, lower cell toxicity, and optimal drug release profile at low pH, similar to the pH in the tumor microenvironment. The HCSs also displayed excellent immunocompatibility and could rapidly distribute themselves in the cytoplasm to escape lysosomal clearance. More importantly, the HCSs could efficiently deliver doxorubicin (a representative chemotherapeutic drug) to tumor sites, which resulted in significant inhibition of tumor growth in an esophageal xenograft cancer model. This also prolonged the circulation time and altered the biodistribution of the drug. In conclusion, this study revealed a novel drug delivery system for targeted tumor therapy. Keywords: hollow carbon spheres, drug delivery, doxorubicin, esophagus carcinomaZhang LYao MYan WLiu XJiang BQian ZGao YLu XJChen XWang QDove Medical Pressarticlehollow carbon spheresdrug deliverydoxorubicinesophageal cancerMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 6759-6769 (2017)
institution DOAJ
collection DOAJ
language EN
topic hollow carbon spheres
drug delivery
doxorubicin
esophageal cancer
Medicine (General)
R5-920
spellingShingle hollow carbon spheres
drug delivery
doxorubicin
esophageal cancer
Medicine (General)
R5-920
Zhang L
Yao M
Yan W
Liu X
Jiang B
Qian Z
Gao Y
Lu XJ
Chen X
Wang Q
Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
description Li Zhang,1,* Mengchu Yao,2,3,* Wei Yan,4,* Xiaoning Liu,5 Baofei Jiang,6 Zhaoye Qian,2,3 Yong Gao,2,3 Xiao-jie Lu,7 Xiaofei Chen,2 Qi-long Wang2,3,5 1Department of Hematology, 2Department of Clinical Oncology, 3Huai’an Key Laboratory of Esophageal Cancer Biobank, 4Department of Gastroenterology, 5Department of Central Laboratory, 6Department of Gastrointestinal Surgery, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, 7Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China *These authors contributed equally to this work Abstract: Low toxicity and high efficacy are the key factors influencing the real-world clinical applications of nanomaterial-assisted drug delivery. In this study, novel hollow carbon spheres (HCSs) with narrow size distribution were developed. In addition to demonstrating their ease of synthesis for large-scale production, we also demonstrated in vitro that the HCSs possessed high drug-loading capacity, lower cell toxicity, and optimal drug release profile at low pH, similar to the pH in the tumor microenvironment. The HCSs also displayed excellent immunocompatibility and could rapidly distribute themselves in the cytoplasm to escape lysosomal clearance. More importantly, the HCSs could efficiently deliver doxorubicin (a representative chemotherapeutic drug) to tumor sites, which resulted in significant inhibition of tumor growth in an esophageal xenograft cancer model. This also prolonged the circulation time and altered the biodistribution of the drug. In conclusion, this study revealed a novel drug delivery system for targeted tumor therapy. Keywords: hollow carbon spheres, drug delivery, doxorubicin, esophagus carcinoma
format article
author Zhang L
Yao M
Yan W
Liu X
Jiang B
Qian Z
Gao Y
Lu XJ
Chen X
Wang Q
author_facet Zhang L
Yao M
Yan W
Liu X
Jiang B
Qian Z
Gao Y
Lu XJ
Chen X
Wang Q
author_sort Zhang L
title Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
title_short Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
title_full Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
title_fullStr Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
title_full_unstemmed Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
title_sort delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/d4e94891176e477cab489b28ec71d8bb
work_keys_str_mv AT zhangl deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT yaom deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT yanw deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT liux deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT jiangb deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT qianz deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT gaoy deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT luxj deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT chenx deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
AT wangq deliveryofachemotherapeuticdrugusingnovelhollowcarbonspheresforesophagealcancertreatment
_version_ 1718402010784464896